LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Mobile Technology & AI
• Education
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

cases, article, mfs, tumour, imd, liposarcoma, mrls, progression, vegf, malignant, access, privacy, cookies, content, area, myxofibrosarcoma, cell, angiogenesis, sarcoma, correlation, mrna, type, myxoid, cells, information, publish, search, vascularity, analysed, histological, thrombospondin, expressed, department, pathology, data, log, journal, research, virchows, myxoidround, mentzel, brown, dvorak, factor, expression, collagen, lowgrade, increased, highgrade, areas,

Topics {✒️}

tumor-targeted image-guided surgery month download article/chapter myxoid/round cell liposarcoma sickle-shaped blood vessels intermediate-grade malignant lesions high-grade malignant neoplasms high-grade malignant mfs low-grade malignant mfs high-grade malignant cases round cell liposarcoma myxoid/round liposarcoma low-grade malignant privacy choices/manage cookies full article pdf related subjects analysed tumour area inhibit angiogenesis tumour cells round cell areas morphologic tumour progression distinct vascular patterns infiltrating growth pattern intimal sarcoma high proliferative activity scope submit manuscript intratumoral microvessel density established diagnostic criteria neovascular hot spots european economic area conditions privacy policy important factor check access instant access total analysed area vegf receptor mrna angiogenesis mfs varied histologically accepting optional cookies characteristic expression profile myxoid liposarcoma necrosis sarcoma journal finder publish tumour progression article log university hospital bergmannsheil article mentzel virchows arch 438 article cite myxoid area

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma
         description: Angiogenesis is an important factor in the morphological progression and metastasis of many solid tumours. We studied two homogeneous series of myxofibrosarcoma (MFS) and myxoid/round liposarcoma (MRLS), characterised by distinct vascular patterns and correlated the intratumoral microvessel density (IMD) with morphologic progression in both types of sarcoma. In our study, 43 cases of MFS and 42 cases of MRLS were graded according to established diagnostic criteria. For evaluation of IMD, representative sections were stained immunohistochemically for CD31. After selection of "neovascular hot spots", IMD was calculated by measuring the endothelial surface within twenty 200× fields in relation to the total analysed area. In addition to the correlation of IMD with histological grades of malignancy, a correlation of IMD with the inflammatory infiltrate in MFS was done. To determine whether vascular endothelial growth factor (VEGF) and its receptors, KDR and flt-1, may play a role in the progression of both types of sarcomas, we used mRNA in situ hybridisation (ISH) to study VEGF, KDR and flt-1 expression in selected cases. In addition, the expression of thrombospondin-1, which has been reported to inhibit angiogenesis, and of collagen type  I was studied using mRNA ISH. Cases of MFS varied histologically from hypocellular, mainly myxoid, neoplasms (low-grade malignant, 18 cases) to intermediate-grade malignant lesions with increased cellularity and mitotic activity (13 cases), and high-grade malignant cases with marked pleomorphism, high proliferative activity and areas of necrosis in many cases (12 cases). Cases of purely low-grade myxoid liposarcoma (16 cases) were characterised by low-cellularity, mucin pooling and plexiform vasculature. In combined MRLS, these hypocellular areas were admixed with hypercellular, round cell areas (5–80% of the analysed tumour area; 23 cases), and in round cell liposarcoma (three cases) rounded tumour cells predominated (>80% of the analysed tumour area). The average IMD in intermediate and high-grade malignant MFS (4.03 and 4.09, respectively) was significantly higher than in low-grade malignant MFS (2.73). Correlation of vascularity with the inflammatory infiltrate in MFS showed increased IMD only in cases with abundant neutrophils; most of these cases were high-grade malignant neoplasms. In contrast, no statistical correlation between morphological progression and IMD was seen in myxoid liposarcoma (6.08), MRLS (6.57) and round cell liposarcoma (4.07). VEGF mRNA was expressed by tumour cells in all histological grades of MFS and MRLS. VEGF receptor mRNA was weakly expressed by endothelia of newly formed blood vessels in both entities. Interestingly, tumour cells of all analysed cases of MFS strongly expressed collagen type I and thrombospondin-1, while these proteins were not detected in tumour cells of MRLS. In conclusion, morphologic tumour progression in MFS is associated with increased IMD, whereas, in MRLS, no such correlation is seen. Whereas VEGF and VEGF receptor mRNA were expressed in both entities, a characteristic expression profile of collagen type I and thrombospondin-1 in MFS emerged. Further studies are necessary to correlate vascularity and clinical course in MFS and MRLS.
         datePublished:
         dateModified:
         pageStart:13
         pageEnd:22
         sameAs:https://doi.org/10.1007/s004280000327
         keywords:
            Angiogenesis VEGF Thrombospondin Sarcoma Soft tissue tumour Myxofibrosarcoma Liposarcoma
            Pathology
         image:
         isPartOf:
            name:Virchows Archiv
            issn:
               1432-2307
               0945-6317
            volumeNumber:438
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:T. Mentzel
               affiliation:
                     name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany
                     address:
                        name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L.F. Brown
               affiliation:
                     name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
                     address:
                        name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H.F. Dvorak
               affiliation:
                     name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
                     address:
                        name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Kuhnen
               affiliation:
                     name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany
                     address:
                        name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K.J. Stiller
               affiliation:
                     name:Department of Pathology, University of Jena, Germany
                     address:
                        name:Department of Pathology, University of Jena, Germany,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Katenkamp
               affiliation:
                     name:Department of Pathology, University of Jena, Germany
                     address:
                        name:Department of Pathology, University of Jena, Germany,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C.D.M. Fletcher
               affiliation:
                     name:Department of Pathology, Brigham and Women's Hospital, Boston, USA
                     address:
                        name:Department of Pathology, Brigham and Women's Hospital, Boston, USA,
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma
      description: Angiogenesis is an important factor in the morphological progression and metastasis of many solid tumours. We studied two homogeneous series of myxofibrosarcoma (MFS) and myxoid/round liposarcoma (MRLS), characterised by distinct vascular patterns and correlated the intratumoral microvessel density (IMD) with morphologic progression in both types of sarcoma. In our study, 43 cases of MFS and 42 cases of MRLS were graded according to established diagnostic criteria. For evaluation of IMD, representative sections were stained immunohistochemically for CD31. After selection of "neovascular hot spots", IMD was calculated by measuring the endothelial surface within twenty 200× fields in relation to the total analysed area. In addition to the correlation of IMD with histological grades of malignancy, a correlation of IMD with the inflammatory infiltrate in MFS was done. To determine whether vascular endothelial growth factor (VEGF) and its receptors, KDR and flt-1, may play a role in the progression of both types of sarcomas, we used mRNA in situ hybridisation (ISH) to study VEGF, KDR and flt-1 expression in selected cases. In addition, the expression of thrombospondin-1, which has been reported to inhibit angiogenesis, and of collagen type  I was studied using mRNA ISH. Cases of MFS varied histologically from hypocellular, mainly myxoid, neoplasms (low-grade malignant, 18 cases) to intermediate-grade malignant lesions with increased cellularity and mitotic activity (13 cases), and high-grade malignant cases with marked pleomorphism, high proliferative activity and areas of necrosis in many cases (12 cases). Cases of purely low-grade myxoid liposarcoma (16 cases) were characterised by low-cellularity, mucin pooling and plexiform vasculature. In combined MRLS, these hypocellular areas were admixed with hypercellular, round cell areas (5–80% of the analysed tumour area; 23 cases), and in round cell liposarcoma (three cases) rounded tumour cells predominated (>80% of the analysed tumour area). The average IMD in intermediate and high-grade malignant MFS (4.03 and 4.09, respectively) was significantly higher than in low-grade malignant MFS (2.73). Correlation of vascularity with the inflammatory infiltrate in MFS showed increased IMD only in cases with abundant neutrophils; most of these cases were high-grade malignant neoplasms. In contrast, no statistical correlation between morphological progression and IMD was seen in myxoid liposarcoma (6.08), MRLS (6.57) and round cell liposarcoma (4.07). VEGF mRNA was expressed by tumour cells in all histological grades of MFS and MRLS. VEGF receptor mRNA was weakly expressed by endothelia of newly formed blood vessels in both entities. Interestingly, tumour cells of all analysed cases of MFS strongly expressed collagen type I and thrombospondin-1, while these proteins were not detected in tumour cells of MRLS. In conclusion, morphologic tumour progression in MFS is associated with increased IMD, whereas, in MRLS, no such correlation is seen. Whereas VEGF and VEGF receptor mRNA were expressed in both entities, a characteristic expression profile of collagen type I and thrombospondin-1 in MFS emerged. Further studies are necessary to correlate vascularity and clinical course in MFS and MRLS.
      datePublished:
      dateModified:
      pageStart:13
      pageEnd:22
      sameAs:https://doi.org/10.1007/s004280000327
      keywords:
         Angiogenesis VEGF Thrombospondin Sarcoma Soft tissue tumour Myxofibrosarcoma Liposarcoma
         Pathology
      image:
      isPartOf:
         name:Virchows Archiv
         issn:
            1432-2307
            0945-6317
         volumeNumber:438
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:T. Mentzel
            affiliation:
                  name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany
                  address:
                     name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L.F. Brown
            affiliation:
                  name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
                  address:
                     name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H.F. Dvorak
            affiliation:
                  name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
                  address:
                     name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Kuhnen
            affiliation:
                  name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany
                  address:
                     name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K.J. Stiller
            affiliation:
                  name:Department of Pathology, University of Jena, Germany
                  address:
                     name:Department of Pathology, University of Jena, Germany,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Katenkamp
            affiliation:
                  name:Department of Pathology, University of Jena, Germany
                  address:
                     name:Department of Pathology, University of Jena, Germany,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C.D.M. Fletcher
            affiliation:
                  name:Department of Pathology, Brigham and Women's Hospital, Boston, USA
                  address:
                     name:Department of Pathology, Brigham and Women's Hospital, Boston, USA,
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Virchows Archiv
      issn:
         1432-2307
         0945-6317
      volumeNumber:438
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany
      address:
         name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany,
         type:PostalAddress
      name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
      address:
         name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
         type:PostalAddress
      name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
      address:
         name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
         type:PostalAddress
      name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany
      address:
         name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany,
         type:PostalAddress
      name:Department of Pathology, University of Jena, Germany
      address:
         name:Department of Pathology, University of Jena, Germany,
         type:PostalAddress
      name:Department of Pathology, University of Jena, Germany
      address:
         name:Department of Pathology, University of Jena, Germany,
         type:PostalAddress
      name:Department of Pathology, Brigham and Women's Hospital, Boston, USA
      address:
         name:Department of Pathology, Brigham and Women's Hospital, Boston, USA,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:T. Mentzel
      affiliation:
            name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany
            address:
               name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany,
               type:PostalAddress
            type:Organization
      name:L.F. Brown
      affiliation:
            name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
            address:
               name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
               type:PostalAddress
            type:Organization
      name:H.F. Dvorak
      affiliation:
            name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA
            address:
               name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
               type:PostalAddress
            type:Organization
      name:C. Kuhnen
      affiliation:
            name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany
            address:
               name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany,
               type:PostalAddress
            type:Organization
      name:K.J. Stiller
      affiliation:
            name:Department of Pathology, University of Jena, Germany
            address:
               name:Department of Pathology, University of Jena, Germany,
               type:PostalAddress
            type:Organization
      name:D. Katenkamp
      affiliation:
            name:Department of Pathology, University of Jena, Germany
            address:
               name:Department of Pathology, University of Jena, Germany,
               type:PostalAddress
            type:Organization
      name:C.D.M. Fletcher
      affiliation:
            name:Department of Pathology, Brigham and Women's Hospital, Boston, USA
            address:
               name:Department of Pathology, Brigham and Women's Hospital, Boston, USA,
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Dermatohistopathologisches Gemeinschaftslabor, Siemensstrasse 6/1, 88048 Friedrichshafen, Germany,
      name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
      name:Department of Pathology, Beth Israel Deaconess Medical Centre, Boston, USA,
      name:Department of Pathology, University Hospital Bergmannsheil, Bochum, Germany,
      name:Department of Pathology, University of Jena, Germany,
      name:Department of Pathology, University of Jena, Germany,
      name:Department of Pathology, Brigham and Women's Hospital, Boston, USA,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(37)

• Explore the financials of https://www.springernature.com/gp/authors
• Revenue of https://link.springernature.com/home/
• How much revenue does https://order.springer.com/public/cart generate?
• How much profit does https://www.editorialmanager.com/viar generate?
• Profit of https://www.springernature.com/gp/librarians/licensing/agc/journals
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Mentzel?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Mentzel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L.F.%20Brown bring in?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L.F.%20Brown%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.F.%20Dvorak?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.F.%20Dvorak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.%20Kuhnen generate?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.%20Kuhnen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K.J.%20Stiller is on a monthly basis
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K.J.%20Stiller%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Katenkamp pull in monthly?
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Katenkamp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.D.M.%20Fletcher?
• How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.D.M.%20Fletcher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
• What's the revenue for https://s100.copyright.com/AppDispatchServlet?title=The%20association%20between%20tumour%20progression%20and%20vascularity%20in%20myxofibrosarcoma%20and%20myxoid%2Fround%20cell%20liposarcoma&author=T.%20Mentzel%20et%20al&contentID=10.1007%2Fs004280000327©right=Springer-Verlag&publication=0945-6317&publicationDate=2001-01&publisherName=SpringerNature&orderBeanReset=true?
• Monthly income for https://citation-needed.springer.com/v2/references/10.1007/s004280000327?format=refman&flavour=citation
• Discover the revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• Check the income stats for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• What's the revenue for https://www.springernature.com/gp/products?
• Discover the revenue of https://www.springernature.com/gp/librarians
• How much does https://www.springernature.com/gp/societies pull in?
• Income figures for https://www.springernature.com/gp/partners
• How much profit does https://www.springer.com/ make?
• How profitable is https://www.nature.com/?
• How much revenue does https://www.biomedcentral.com/ bring in?
• What's the financial gain of https://www.palgrave.com/?
• How much does https://www.apress.com/ pull in monthly?
• How much does https://www.springernature.com/gp/legal/ccpa make?
• How much does https://www.springernature.com/gp/info/accessibility earn?
• What's the profit of https://support.springernature.com/en/support/home?
• How much money does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
• How much does https://www.springernature.com/ bring in each month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js